Thiogenesis Announces Addition of Dr. Vince Stanton Jr. to Its Scientific Advisory Board #Investing #InvestmentBanking #SmallCaps #TSXV #TTI.CA #TTI.V
San Diego, California--(Newsfile Corp. - November 27, 2023) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing sulfur-containing therapeutics for unmet pediatric diseases, today announced the addition of Vincent Stanton Jr., MD to its Scientific Advisory Board ("SAB"). Dr. Stanton was a co-founder of Thiogenesis Therapeutics, Inc., dating back to February 2016.Dr. Vincent Stanton Jr., MD is an entrepreneur and...
http://dlvr.it/SzN48y
http://dlvr.it/SzN48y
Comments
Post a Comment